Search

everythinglearnresearchcommunity

for

Search:↓

Brimonidine is effective for reducing facial redness in skin conditions and has potential for broader dermatological uses.

L-PRF may help bone growth and healing, but more research is needed.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

A woman with lupus also developed a severe skin condition linked to a genetic factor.

Photodynamic therapy shows promise for oral lichen planus but needs more research for consistent results.

New techniques and findings in dermatologic surgery show improved pain management, safer liposuction, better hair transplantation, and effective treatments for skin conditions.

Companies agreed to stop making false health claims about their products.

Laser-assisted delivery of PRP, with or without bimatoprost and minoxidil, can effectively stimulate hair growth.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

CSC is linked to mineralocorticoid receptor damage, stress, and steroid use, with treatments including drugs and laser therapies to prevent eye damage.

The document concludes that careful surgical methods and choosing the right materials are key for successful scalp, skull, and frontal sinus reconstruction.

The document concludes that early diagnosis of Balint's syndrome is crucial for effective treatment and that understanding drug interactions, like between ritonavir and statins, is important for patient care.

Peripheral nerve blocks are a safe and effective way to treat various headaches and provide lasting pain relief.

A man's relapsed leprosy was successfully treated with the antibiotic sparfloxacin.

Advocacy groups should avoid marketing partnerships that may imply drug endorsements.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

Belimumab effectively reduces disease activity in lupus patients, regardless of initial serologic status.

Light-based bioelectronic devices improve health monitoring and disease treatment.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.